Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Teva Branded Pharmaceutical Products R&D, Inc."
Count: 407
Selected: 0
| NCT ID | Title |
|---|
| NCT04464707 | A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Patients 6 to 17 Years of Age | ||
| NCT04458857 | A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age | ||
| NCT05693935 | A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia | ||
| NCT05458011 | A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine | ||
| NCT06052267 | A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations | ||
| NCT05499130 | A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease | ||
| NCT05668013 | A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease | ||
| NCT04041284 | A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder | ||
| NCT02025556 | A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine | ||
| NCT03813238 | A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents | ||
| NCT00724048 | A Study of Pridopidine (ACR16) for the Treatment of Participants With Huntington's Disease | ||
| NCT00665223 | A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's Disease | ||
| NCT01311713 | Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors | ||
| NCT04530110 | A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents | ||
| NCT04682353 | A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age | ||
| NCT01348919 | Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma | ||
| NCT00232999 | Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma | ||
| NCT04847674 | A Study to Test if TEV-53275 is Effective in Relieving Asthma | ||
| NCT01596621 | A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment | ||
| NCT02817464 | Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle | ||
| NCT03571256 | A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS) | ||
| NCT03567291 | Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents | ||
| NCT03452943 | Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents | ||
| NCT00932581 | Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties | ||
| NCT03965091 | A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia | ||
| NCT01126190 | Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel | ||
| NCT04677959 | A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma | ||
| NCT04545385 | A Study to Test if TEV-48574 is Effective in Relieving Asthma | ||
| NCT04200352 | A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy | ||
| NCT03503318 | Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia | ||
| NCT00837265 | Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel | ||
| NCT03052725 | A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma | ||
| NCT03347188 | A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH) | ||
| NCT03029000 | Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants | ||
| NCT03893825 | A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia | ||
| NCT03890666 | A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma | ||
| NCT00530062 | Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With Asthma | ||
| NCT02062463 | Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With Asthma | ||
| NCT01085084 | A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis | ||
| NCT02044276 | A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia | ||
| NCT00462943 | Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML | ||
| NCT00605215 | BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®) | ||
| NCT00375219 | Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation | ||
| NCT01803555 | Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER® | ||
| NCT00308685 | Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics | ||
| NCT02487108 | Study to Evaluate the Analgesic Efficacy and Safety of Hydrocodone Bitartrate/Acetaminophen Immediate-Release Tablets in Participants With Moderate to Severe Pain Following Bunionectomy | ||
| NCT02284568 | A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo | ||
| NCT01085097 | A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis | ||
| NCT01056159 | A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler) | ||
| NCT03700658 | A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046 |
